CLINICAL_TRIALS trial_result · 2019-04-23

Clinical Trial Update: Apixaban Versus Warfarin in the Evaluation of Progression of Atherosclerotic Calcification and Vulnerable Plaque [Phase 4]

View source ↗

Summary

Phase 4 trial comparing apixaban to warfarin examining progression of atherosclerotic calcification and vulnerable plaque in patients with atrial fibrillation; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

Snippet

Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Conditions: Atrial Fibrillation | Phase 4 | Status: COMPLETED | Results posted: 2019-04-23